Germany
Japan
United Kingdom
China
USD 630.00
2 Weeks
Antibodies
View as table Download
USD 630.00
2 Weeks
Recombinant Anti-CD40L (Clone hu5c8 (Ruplizumab))
| Applications | Bl, FC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD80 (Clone IDEC-114 (Galiximab))
| Applications | Bl, ELISA, FC, IHC, IP, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
USD 630.00
2 Weeks
Recombinant Anti-alpha 5 beta 1 Integrin (Clone M200 (Volociximab))
| Applications | Bl, ELISA, FC, IF, IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD11a (Clone hu1124 (Efalizumab))
| Applications | Bl, FC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-VEGF (Clone Bevacizumab)
| Applications | Bl, ELISA, FC, IP, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD40 (Clone 5D12)
| Applications | Bl, ELISA, FC, IHC, IP |
| Reactivities | Human, Cynomolgus, Monkey |
| Conjugation | Unconjugated |
Recombinant Anti-TNF alpha (Clone D2E7 (Adalimumab))
| Applications | Bl, ELISA, IF, IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-EGFR domain III (Clone h-R3 (Nimotuzumab))
| Applications | Bl, FC, IHC |
| Reactivities | Human |
| Conjugation | Unconjugated |
Recombinant Anti-CD22 (Clone hL22 (Epratuzumab))
| Applications | Bl, FC, IP |
| Reactivities | Human, Monkey |
| Conjugation | Unconjugated |
Recombinant Anti-CD41 (Clone 7E3 (Abciximab))
| Applications | Bl, FC |
| Reactivities | Human |
| Conjugation | Unconjugated |